Are modern environments really bad for us? Revisiting the demographic and epidemiologic transitions

Yearbook of Physical Anthropology

Volumn 48, Issue , 2005, Pages 96-117

  Gage, Timothy B ^a,b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Cause of death; Demographic transition; Epidemiologic transition; Mortality

Indexed keywords

EID: 32144458925     PISSN: 0096848X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajpa.20353     Document Type: Review

References (94)

1. Acsadi G, Nemeskeri J. 1970. History of human life span and mortality. Budapest: Akademiai Kiado.
2. Antia R, Regoes RR, Koella JC, Bergstrom CT. 2003. The role of evolution in the emergence of infectious diseases. Nature 426: 658-661.
3. Azambuja MIR, Duncan BB. 2002. Similarities in mortality patterns from influenza in the first half of the 20th century and the rise and fall of ischemic heart disease in the United States: a new hypothesis concerning the coronary heart disease epidemic. Cad Saude Publica 18:557-577.
4. Barker DJP. 1989. Rise and fall of Western diseases. Nature 338:371-372.
5. Barker DJP. 1999. The fetal origins of coronary heart disease and stroke: evolutionary implications. In: Stearns SC, editor. Evolution in health and disease. Oxford: Oxford University Press, p 246-250.
6. Barrett R, Kuzawa CW, McDade T, Armelagos GJ. 1998. Emerging and re-emerging infectious diseases: the third epidemiological transition. Annu Rev Anthropol 27:247-271.
7. Becker N. 1998. Cancer mortality and prevention in the European Union. Eur J Surg Oncol 24:370-374.
8. Bull JJ. 1994. Perspective: virulence. Evolution 48:1423-1437.
9. Burke G, Sprafka J, Folsom A, Luepker R, Norsted S, Blackburn H. 1989. Trends in CHD mortality, morbidity, and risk factor levels from 1960 to 1986: the Minnesota Heart Survey. Int J Epidemiol [Suppl] 18:73-81.
10. Coale AJ, Demeny P, Vaughan B. 1983. Regional model life tables and stable populations. New York: Academic Press.
11. Cohen MN. 1989. Health and the rise of civilzation. New Haven: Yale University Press.
12. Cohen MN, Armelagos GJ, editors. 1984. Paleo-pathology at the origins of agriculture. Orlando: Academic Press.
13. Costa DL. 2000. Understanding the 20th century decline in chronic conditions among older men. Demography 37:53-72.
14. Crimmins EM. 2004. Trends in the health of the elderly. Annu Rev Public Health 25:79-98.
15. Crimmins EM, Saito Y. 2000. Changes in the prevalence of diseases among older Americans: 1984-1994. Demogr Res Vol. 3-9. http://www.demographic- research.org.
16. Cutler DM, Miller G. 2005. The role of public health improvements in health advances. Demography 42:1-22.
17. Cutler DM, Richardson E. 1997. Measuring the health of the U.S. population. In: Baily M, Reiss P, Winston C, editors. Brookings papers on economic activity: microecomonics. Washington, DC: Brookings Institute, p. 217-271.
18. Davenport F. 1976. Influenza viruses. In: Evans AS, editor. Viral infections of humans: epidemiology and control. New York: Plenum Press, p 373-396.
19. Demirovic J, Blackburn H, McGovern P, Sprafka J, Doliszny K. 1993. Sex differences in coronary heart disease mortality trends: the Minnesota Heart Survey, 1970-1988. Epidemiology 4:79-82.
20. Dobson M. 1997. Contours of death and disease in early modern England. Cambridge: Cambridge University Press.
21. Doll R, Peto R. 2001. The causes of cancer. Rev Epidemiol Sante Publique 49:193-200.
22. Eaton SB, Eaton SB III. 1999. The evolutionary context of chronic degenerative diseases. In: Stearns SC, editor. Evolution in health and disease. Oxford: Oxford University Press, p 251-259.
23. Eaton SB, Konner M, Shostak M. 1988. Stone Agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Q Rev Biol 69:353-367.
24. Ebert D. 1999. The evolution and expression of parasite virulence. In: Stearns SC, editor. Evolution in health and disease. Oxford: Oxford University Press, p 161-171.
25. Ewald PW. 2000. Plague time. New York: Anchor Books.
26. Fenner F. 1970. The effects of changing social organization on the infectious diseases of man. In: Boyden SV, editor The impact of civilization on the biology of man. Canberra: Australian National University Press, p 48-76.
27. Floud R, Wachter K, Gregory A. 1990. Height, health and history. Cambridge: Cambridge University Press.
28. Fogel RW. 2005. Changes in the disparities in chronic diseases during the course of the 20th century. Perspect Biol Med 48: 150-165.
29. Fogel RW, Engerman SL, Trussell J. 1982. Exploring the uses of data on height: The analysis of long-term trends in nutrition, labor welfare and labor productivity. Soc Sci Hist 6: 401.
30. Gage TB. 1988. Mathematical hazard models of mortality: an alternative to model life tables. Am J Phys Antrhopol 76:429-441.
31. Gage TB. 1991. Causes of death and the components of mortality: testing the biological interpretations of a competing hazards model. Am J Hum Biol 3:289-300.
32. Gage TB. 1993. The decline of mortality in England and Wales 1861 to 1964: an analysis using competing hazards models. Popul Stud 47:47-66.
33. Gage TB. 1994. Population variation in cause of death: level, gender and period effects. Demography 31:271-296.
34. Gage TB. 2000. Demography. In: Stinson S, Bogin B, Huss-Ashmore R, O'Rourke D, editors. Human Biology: an evolutionary and biocultural approach. New York: John Wiley and Sons. p 507-552.
35. Gage TB, McCullough JM, Weitz CA, Dutt JS, Abelson A. 1989. Demographic studies in human population biology. In: Little M, Haas J, editors. Human population biology: a transdisciplinary science. Oxford: Oxford University Press, p 45-68.
36. Gersten O, Wimoth JR. 2002. The cancer transition in Japan since 1951. Demogr Res 7:272-306.
37. Godfrey KM, Barker DJP. 2000. Fetal nutrition and adult disease. Am J Clin Nutr 71:1344-1352.
38. Grayston JT. 2000. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 181:402-410.
39. Havlik RJ, Feinleib M, editors. 1979. Proceedings of the conference on the decline in coronary heart disease mortality. NIH publication no. 79-1610. Washington, DC: US Department of Health, Education and Welfare.
40. Hinde A. 2003. England's population: a history since the Domesday Survey. New York: Oxford University Press.
41. Holmes EC. 1999. Molecular phylogenies and the genetic structure of viral populations. In: Stearns SC, editor. Evolution in health and disease. Oxford: Oxford University Press, p 173-182.
42. Holmes EC. 2004. The phylogeography of human viruses. Mol Evol 13:745-756.
43. Hoppa RD, Vaupel JW, editors. 2002. Paleodemograhy. Cambridge: Cambridge University Press.
44. Howell N. 1982. Village composition implied by a paleodemographic lifetable: the Libben Site. Am J Phys Anthropol 59: 263-269.
45. Human Mortality Database. 2004. University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany). Available at www.mortality.org or www. humanmortality.de.
46. Hunimk MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA. 1997. The recent decline in mortality from coronary heart disease, 1980-1990: the effect of secular trends in risk factors and assessment. JAMA 277:534-542.
47. Lancaster HO. 1990. Expectation of life. New York: Springer-Verlag.
48. Lee RD, Carter LR. 1992. Modeling the forecasting of U.S. mortality. J Am Stat Assoc 87:659-675.
49. Livi-Bacci. 2000. The population of Europe. Oxford: Blackwell.
50. Lovejoy CO, Meindl RS, Pryzbeck TR, Barton TS, Heiple KG, Knotting D. 1977. Paleodemography of the Libben Site, Ottawa County, Ohio. Science 198:329-352.
51. Manton KG, Stallard E. 1984. Recent trends in mortality analysis. London: Academic Press.
52. Manton KG, Stallard E, Corder L. 1995. Changes in morbidity and chronic disability in the U.S. elderly population: evidence from the 1982, 1984, and 1989 National Long Term Care Surveys. J Gerontol 50:194-204.
53. Martelin T. 1987. Trends in elderly mortality in the Nordic countries. Compr Gerontol [C] 1:39-48.
54. Maynard Smith J, Barker JP, Finch CE, Jardia SLR, Eaton SB, Kirkwood TBL, LeGrand E, Ness RM, Williams GC, Partidge L. 1999. The evolution of non-infectious and degenerative disease. In: Stearns SC, editor. Evolution in health and disease. Oxford: Oxford University Press, p 267-272.
55. McGovern PG, Folsom AR, Sprafka JM, Burke GL, Doliszny KM, et al. 1992. Trends in survival of hospitalized myocardial infarction patients between 1970 and 1985: the Minnesota Heart Survey. Circulation 85:172-179.
56. McGovern PG, Pankow JS, Shahar E, Doliszny KM, Folsom AR, et al. 1996. Recent trends in acute coronary heart disease: mortality, morbidity, medical care, and risk factors. N Engl J Med 334:884-890.
57. McKeown T. 1976. The modern rise of population. New York: Academic Press.
58. Mesle F. 2004. Mortality in Central and Eastern Europe: long-term trends and recent upturns. Demogr Res 3:46-70.
59. Moore JA, Swedlund AC, Armelagos GJ. 1975. The use of life tables in paleodemography. In: Swedlund AC, editor. Population studies in archaeology and biological anthropology: a symposium: memoirs of the Society for American Archaeology. Washington DC: Society for American Archaeology, p 57-70.
60. Murray CJL, Lopez AD, editors. 1996. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard School of Public Health.
61. National Cancer Institute. 1999. Cancer death rates among 50 countries. http://rex.nci.nih.gov/NIC_Pub_Interface/raterisk/rates34.html.
62. National Center for Health Statistics. 1978. Comparability of cause-of-death statistics, figures, tables, and technical notes describing trends in ischémic heart disease mortality. Hyattsville, MD: US Department of Health, Education, and Welfare.
63. Nesse RM, Williams G. 1994. Why we get sick: the new science of Darwinian medicine. New York: Times Books.
64. Nesse RM, Williams GC. 1999. Research designs that address evolutionary questions about medical disorders. In: Stearns SC, editor. Evolution in health and disease. Oxford: Oxford University Press, p 16-22.
65. Olshansky SJ, Ault AB. 1986. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. Milbank Q 64:355-91.
66. Omran AR. 1977. Epidemiological transition in the U.S. Popul Bull 32:1-42.
67. Patel P, Mendal MA, Carrington D, Strachan DP, Leatham E, Molineaux N, Levy J, Blakeston C, Seymour CA, Camm AJ, Northfield TC. 1995. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J [Clin Res] 311:711-714.
68. Potter CW. 2002. Influenza. New York: Elsevier.
69. Preston SH. 1976. Mortality patterns in national populations. New York: Academic Press.
70. Preston SH, Haines MR. 1991. Fatal years: child mortality in late nineteenth-century America. Princeton: Princeton University Press.
71. Preston SH, Keyfitz N, Schoen R. 1972. Causes of death: life tables for national populations. New York: Seminar Press.
72. Rogers RG, Hackenberg R. 1987. Extending epidemiologic transition theory: a new stage. Soc Biol 34:234-243.
73. Salomon JA, Murray CJL. 2002. The epidemiologic transition revisited: compositional models for cause of death by age and sex. Popul Dev Rev 28:205-228.
74. Schofield R, Reher D. 1991. The decline in mortality in Europe. In: Schofield R, Reher D, Bideau A, editors. The decline of mortality in Europe. Oxford: Clarendon Press, p 1-17.
75. Siler W. 1979. A competing-risk model for animal mortality. Ecology 60:750-757.
76. Stallones RA. 1980. The rise and fall of ischemic heart disease. Sci Am 243:53-59.
77. Stearns SC. 1992. The evolution of life histories. Oxford: Oxford University Press.
78. Stearns SC, editor. 1999. Evolution in health and disease. Oxford: Oxford University Press.
79. Strassmann BI, Dunbar RIM. 1999. Human evolution and disease: putting the Stone Age in perspective. In: Stearns SC, editor. Evolution in health and disease. Oxford: Oxford University Press, p 91-100.
80. Szreter S. 1989. The importance of social intervention in Britain's mortality decline c. 1850-1914: a re-interpretation of the role of public health. Soc Hist Med 1:1-37.
81. Thompson W. 1929. Population. Am J Sociol 34:959-975.
82. Vallin J. 1991. Mortality in Europe from 1720 to 1914: long-term trends and changes in patterns by age and sex. In: Schofield R, Reher D, Bideau A, editors. The decline of mortality in Europe. Oxford: Clarendon Press, p 38-67.
83. Vallin J, Mesle F. 2004. Convergences and divergences in mortality. A new approach to health transition. Demogr Res 2:12-44.
84. Van Blerkom LM. 2003. Role of viruses in human evolution. Yrbk Phys Anthropol 46:14-46.
85. White KM. 1999. Cardiovascular and tuberculosis mortality: the contrasting effects of changes in two causes of death. Popul Dev Rev 25:289-302.
86. Wilson C. 2001. On the scale of global demographic convergence 1950-2000. Popul Dev Rev 27:155-171.
87. Wolleswinkel-Van-Den-Bosch JH, Looman CWN, Van-Poppel FWA, Mackenbach JP. 1997. Cause-specific mortality trends in the Netherlands, 1875-1992: a formal analysis of the epidemiologic transition. Int J Epidemiol 26:772-781.
88. Wood JW, Milner GR, Harpending HC, Weiss KM. 1992. The osteological paradox. Curr Anthropol 33:343-370.
89. Woods R. 1991. Public health and public hygiene: the urban environment in the late nineteenth and early twentieth centuries. In: Schofield R, Reher D, Bideau A, editors. The decline of mortality in Europe. Oxford: Clarendon Press, p 234-247.
90. Woods R. 2000. The demography of Victorian England and Wales. Cambridge: Cambridge University Press.
91. World Health Organization. 1955. International Classification of Diseases, Revision 7 Vol 1. Geneva: World Health Organization.
92. Wrigley EA, Schofield RS. 1981. The population history of England: 1541-1871. Cambridge, MA: Harvard University Press.
93. Yanagishita M, Guralnick JM. 1988. Changing mortality patterns that led life expectancy in Japan to surpass Sweden's: 1972-1982. Demography 25:611-624.
94. Zatonski WA, McMichael AJ, Powles JW. 1998. Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991. Br Med J [Clin Res] 316:1047-1051.